Purpose
to develop novel technologies to lower the commercial cost of monoclonal antibodies (mAbs) for infectious diseases in low income markets
Grantee
Division
Global Health
Date
JULY 2015
Region served
GLOBAL
Committed amount
$14,998,577
Grant topic
Vaccine Development
Duration (months)
59
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.